Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial

References

• Hopkins C. Chronic rhinosinusitis with nasal polyps. N Engl J Med. 2019;381(1):55–63. doi:10.1056/NEJMcp1800215
   PubMed Web of Science ®Google Scholar
• Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;14:127–134. doi:10.2147/JAA.S290424
   PubMed Web of Science ®Google Scholar
• Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016;4(4):565–572. doi:10.1016/j.jaip.2016.04.012
   PubMed Web of Science ®Google Scholar
• Abdalla S, Alreefy H, Hopkins C. Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit. Clin Otolaryngol. 2012;37(4):276–282. doi:10.1111/j.1749-4486.2012.02527.x
   PubMed Web of Science ®Google Scholar
• Seys SF, De Bont S, Fokkens WJ, et al. Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA. Allergy. 2020;75(11):2867–2878. doi:10.1111/all.14408
   PubMed Web of Science ®Google Scholar
• Hall R, Trennery C, Chan R, et al. Understanding the patient experience of severe, recurrent, bilateral nasal polyps: a qualitative interview study in the United States and Germany. Value Health. 2020;23(5):632–641. doi:10.1016/j.jval.2019.11.005
   PubMed Web of Science ®Google Scholar
• Vennik J, Eyles C, Thomas M, et al. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care. BMJ Open. 2019;9(4):e022644. doi:10.1136/bmjopen-2018-022644
   PubMed Web of Science ®Google Scholar
• Khan AH, Abbe A, Falissard B, et al. Data mining of free-text responses: an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab. Patient Prefer Adherence. 2021;15:2577–2586. doi:10.2147/PPA.S320242
   PubMed Web of Science ®Google Scholar
• Bhattacharyya N, Villeneuve S, Joish VN, et al. Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope. 2019;129(9):1969–1975. doi:10.1002/lary.27852
   PubMed Web of Science ®Google Scholar
• Khan A, Vandeplas G, Huynh TMT, et al. The Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2019;57(1):32–42. doi:10.4193/Rhin17.255
   PubMed Web of Science ®Google Scholar
• Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–1456.e1444. doi:10.1016/j.jaci.2015.12.1324
   PubMed Web of Science ®Google Scholar
• Khan A, Huynh TMT, Vandeplas G, et al. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology. 2019;57(5):343–351. doi:10.4193/Rhin19.158
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Macdonald LE, Stevens S, et al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci USA. 2014;111(14):5153–5158. doi:10.1073/pnas.1324022111
   PubMed Web of Science ®Google Scholar
• Gandhi NA, Pirozzi G, Graham NMH. Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert Rev Clin Immunol. 2017;13(5):425–437. doi:10.1080/1744666X.2017.1298443
   PubMed Web of Science ®Google Scholar
• Macdonald LE, Karow M, Stevens S, et al. Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes. Proc Natl Acad Sci USA. 2014;111(14):5147–5152. doi:10.1073/pnas.1323896111
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638–1650. doi:10.1016/S0140-6736(19)31881-1
   PubMed Web of Science ®Google Scholar
• Lee SE, Hopkins C, Mullol J, et al. Dupilumab improves health related quality of life: results from the phase 3 SINUS studies. Allergy. 2022;77(7):2211–2221. doi:10.1111/all.15222.
   PubMed Web of Science ®Google Scholar
• Maspero JF, Bachert C, Martinez FJ, et al. Clinical efficacy among patients with chronic rhinosinusitis with nasal polyps and clinical features of obstructive lung disease: post hoc analysis of the Phase III SINUS-24 and SINUS-52 studies. J Asthma Allergy. 2023;: In Press.
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36. doi:10.1016/j.jaci.2020.11.013
   PubMed Web of Science ®Google Scholar
• Hawthorne G, Osborne RH, Taylor A, Sansoni J. The SF36 version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res. 2007;16(4):661–673. doi:10.1007/s11136-006-9154-4
   PubMed Web of Science ®Google Scholar
• Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469–479. doi:10.1001/jama.2015.19330
   PubMed Web of Science ®Google Scholar
• Rand Corporation. 36-item short form survey instrument; 2022. Available from: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/survey-instrument.html. Accessed December 5, 2022.
   Google Scholar
• Ware JE Jr. SF-36 health survey update. Spine. 2000;25(24):3130–3139. doi:10.1097/00007632-200012150-00008
   PubMed Web of Science ®Google Scholar
• Altinkesen E, Gelecek N. Functional status and quality of life in patients with early and late stage rheumatoid arthritis. Fiz Rehabil. 2011;22(2):93–99.
   Google Scholar
• Siroux V, Boudier A, Anto JM, et al. Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy. 2008;63(5):547–554. doi:10.1111/j.1398-9995.2008.01638.x
   PubMed Web of Science ®Google Scholar
• Svedbo Engstrom M, Leksell J, Johansson UB, et al. Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes - a nationwide cross-sectional study. Health Qual Life Outcomes. 2019;17(1):141. doi:10.1186/s12955-019-1212-z
   PubMed Web of Science ®Google Scholar
• EuroQol G. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
   PubMed Web of Science ®Google Scholar
• EuroQol Research Foundation. EQ-5D-Y User Guide; 2020. Available from: https://euroqol.org/publications/user-guides. Accessed March 9, 2023.
   Google Scholar
• Maglinte GA, Hays RD, Kaplan RM. US general population norms for telephone administration of the SF-36v2. J Clin Epidemiol. 2012;65(5):497–502. doi:10.1016/j.jclinepi.2011.09.008
   PubMed Web of Science ®Google Scholar
• Janssen MF, Szende A, Cabases J, Ramos-Goni JM, Vilagut G, Konig HH. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. Eur J Health Econ. 2019;20(2):205–216. doi:10.1007/s10198-018-0955-5
   PubMed Web of Science ®Google Scholar
• Scott M, Chuang C-C, Khan A, Small M, Kamat SA. Clinical characteristics and patient-reported outcomes (PROs) among chronic rhinosinusitis with nasal polyps (CRSwNP) patients with a history of sinus surgery. American Rhinologic Society (ARS) 2019 Annual Meeting; September 13–14; New Orleans, LA, USA; 2019.
   Google Scholar
• Khan AH, Reaney M, Guillemin I, et al. Development of sinonasal outcome test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps. Laryngoscope. 2022;132(5):933–941. doi:10.1002/lary.29766
   PubMed Web of Science ®Google Scholar
• Swinscow TDV. Correlation and regression. In statistics at square one 9th edition; 2021. Available from: https://www.bmj.com/about-bmj/resources-readers/publications/statistics-square-one/11-correlation-and-regression. Accessed December 23, 2021.
   Google Scholar
• Ference EH, Reddy SR, Tieu R, Gokhale S, Park S, Lecocq J. Burden of nasal polyps in the United States. OTO Open. 2020;4(3):2473974X2095072. doi:10.1177/2473974X20950727
   Google Scholar
• Basu S, Georgalas C, Kumar BN, Desai S. Correlation between symptoms and radiological findings in patients with chronic rhinosinusitis: an evaluation study using the sinonasal assessment questionnaire and Lund-Mackay grading system. Eur Arch Otorhinolaryngol. 2005;262(9):751–754. doi:10.1007/s00405-004-0891-0
   PubMed Web of Science ®Google Scholar
• Ryan WR, Ramachandra T, Hwang PH. Correlations between symptoms, nasal endoscopy, and in-office computed tomography in post-surgical chronic rhinosinusitis patients. Laryngoscope. 2011;121(3):674–678. doi:10.1002/lary.21394
   PubMed Web of Science ®Google Scholar
• Bhattacharyya N. Relationship between mucosal inflammation, computed tomography, and symptomatology in chronic rhinosinusitis without polyposis. Ann Otol Rhinol Laryngol. 2008;117(7):517–522. doi:10.1177/000348940811700709
   PubMed Web of Science ®Google Scholar